Literature DB >> 23480766

Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of opisthorchiasis-associated cholangiocarcinoma.

N Namwat1, P Chusorn, W Loilome, A Techasen, J Puetkasichonpasutha, C Pairojkul, N Khuntikeo, P Yongvanit.   

Abstract

Altered miRNA expression could be a determinant of cancer development and/or progression. We aimed to study the role of oncomir miR-21 and tumor suppressor let-7a in the genesis of Opisthorchiasis-associated cholangiocarcinoma (CCA). The results showed that miR-21 was up-regulated while let-7a was down-regulated during cholangiocarcinogenesis in the hamster model and also in human CCA samples. The expression level of miR-21 had an inverse correlation with the mRNA level of its target RECK, a metastasis suppressor, in human CCA. Knockdown of miR-21 of KKU100 CCA cells significantly increased the mRNA level of RECK and suppressed the wound-induced migration of CCA cells. Our data suggest that miR-21 is one key molecule playing crucial roles in the CCA growth and metastasis. Manipulation of miRNA expression offers a potential avenue of CCA therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23480766

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  15 in total

Review 1.  Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy.

Authors:  Domenico Viterbo; Valerie Gausman; Tamas Gonda
Journal:  World J Gastrointest Endosc       Date:  2016-02-10

Review 2.  Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.

Authors:  Hiroaki Haga; Irene Yan; Kenji Takahashi; Joseph Wood; Tushar Patel
Journal:  Gene Expr       Date:  2014

3.  Induction of cancer-related microRNA expression profiling using excretory-secretory products of Clonorchis sinensis.

Authors:  Jhang Ho Pak; In Ki Kim; Seon Min Kim; Sejung Maeng; Kyoung Ju Song; Byoung-Kuk Na; Tong-Soo Kim
Journal:  Parasitol Res       Date:  2014-09-14       Impact factor: 2.289

4.  Overexpression of miR-27a predicts poor prognosis and promotes the progression in cholangiocarcinoma.

Authors:  Yunxia Liu; Xia Liu; Yanhua Zhou; Tingting Liu; Jie Li
Journal:  Clin Exp Med       Date:  2020-08-20       Impact factor: 3.984

5.  MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.

Authors:  Li-Juan Wang; Chen-Chen He; Xin Sui; Meng-Jiao Cai; Cong-Ya Zhou; Jin-Lu Ma; Lei Wu; Hao Wang; Su-Xia Han; Qing Zhu
Journal:  Oncotarget       Date:  2015-03-20

6.  MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.

Authors:  Jeremy S Schaefer; Taraq Attumi; Antone R Opekun; Bincy Abraham; Jason Hou; Harold Shelby; David Y Graham; Charles Streckfus; John R Klein
Journal:  BMC Immunol       Date:  2015-02-10       Impact factor: 3.615

7.  Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by Solexa high-throughput sequencing.

Authors:  Juan Liao; Ran Liu; Lihong Yin; Yuepu Pu
Journal:  Int J Mol Sci       Date:  2014-09-02       Impact factor: 5.923

8.  LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner.

Authors:  Wen-Tao Wang; Hua Ye; Pan-Pan Wei; Bo-Wei Han; Bo He; Zhen- Hua Chen; Yue-Qin Chen
Journal:  J Hematol Oncol       Date:  2016-11-03       Impact factor: 17.388

Review 9.  NcRNAs and Cholangiocarcinoma.

Authors:  Zheng Wangyang; Ji Daolin; Xu Yi; Li Zhenglong; Huang Lining; Cui Yunfu; Jiang Xingming
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

Review 10.  Clonorchis sinensis, an oriental liver fluke, as a human biological agent of cholangiocarcinoma: a brief review.

Authors:  Tong-Soo Kim; Jhang Ho Pak; Jong-Bo Kim; Young Yil Bahk
Journal:  BMB Rep       Date:  2016-11       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.